欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0459/001
药品名称
Clazicon
活性成分
gliclazide 30.0 mg
剂型
Modified-release tablet
上市许可持有人
Synoptis Pharma Sp. z o.o. ul. Krakowiaków 65 02-255 Warszawa
参考成员国 - 产品名称
Poland (PL)
Clazicon
互认成员国 - 产品名称
许可日期
2015/03/24
最近更新日期
2024/01/26
药物ATC编码
A10BB09 gliclazide
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
Final PAR Gliclazid Sigillata 30 mg 60 mg modified release tablets DKH2377_001_002_DC
Date of last change:2024/09/06
PubAR Summary
|
Final sPAR Gliclazid Sigillata 30 mg 60 mg modified release tablets DKH2377_001_002_DC
Date of last change:2024/09/06
Final SPC
|
PI_Gliclazide DK_H_2376_77_99_01_02_DC_Final _CL
Date of last change:2024/09/06
Final Product Information
|
PI_Gliclazide DK_H_2376_77_99_01_02_REVISED after day 210_Final_CL__20150327
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase